Mismatched unrelated alternative donors for hematological malignancies.

Abstract

For the majority of hematologic malignancies allogeneic hematopoietic cell transplantation (HCT) is the only curative treatment option. Sibling donors have been the standard for adult patients. Since there is not a suitable family donor for all patients, the need for alternative donors for HCT is great. Fortunately, the availability of unrelated volunteer donor registries has expanded over the years and the results of HCT with matched unrelated donors (MUD) are comparable to the results with matched related donors (MRD). Nevertheless, there are many patients lacking a well-matched donor. To increase the applicability of transplantation, alternative donors such as mismatched unrelated donors (MMURD), cord blood stem cell products and haploidentical related donors have been widely used. This review seeks to give insights into the use of MMUD donors for HCT and summarize the existing data.

• Authors: Henning Sebastian Schäfer, Jürgen Finke
• Journal: Seminars in hematology (Semin Hematol) Vol. 53 Issue 2 Pg. 77-81 (Apr 2016) ISSN: 1532-8686 [Electronic] United States
• PMID: 27000730 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2016 Elsevier Inc. All rights reserved.

Topics

• Graft Rejection
• Hematologic Neoplasms (therapy)
• Hematopoietic Stem Cell Transplantation
• Humans
• Recurrence
• Transplantation, Homologous
• Unrelated Donors